Outreach and Treatment for Depression in the Labor Force

Depression Clinical Trial

Official title:

Outreach and Treatment for Depression in the Labor Force

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00057590
• Other study ID #: R01MH061941
• Secondary ID: R01MH061941DSIR
• Status: Completed
• Phase: N/A
• First received: April 4, 2003
• Last updated: May 3, 2013
• Start date: March 2003

Study information

• Verified date: May 2013
• Source: Harvard Medical School
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This study will assess the effects of depression treatment on employee productivity. This study will also evaluate the impact of depression screening and outreach on employees' receptivity to treatment.

Description:

This study is conducted in three phases. In the first phase, employees from various companies participate in an on-line Health Risk Assessment survey at a secure website. Those who display symptoms of depression participate in a brief telephone interview to confirm the depression diagnosis.

In the second phase, depressed participants are randomly assigned to receive either intervention treatment or usual care for 18 months. The intervention consists of periodic telephone contact with a mental health clinician who provides education regarding depression and its treatment. Participants receiving the intervention are also provided with resources to obtain psychotherapy and/or pharmacotherapy. Those who do not seek treatment are monitored and supported. Participants in the usual care arm are informed of their possible depression and are encouraged to seek professional treatment.

The final phase of the study involves data analysis and dissemination of aggregated results. Surveys and questionnaires are used to assess participants.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 590
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major depressive episode

• Employed

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Behavioral:
• Care manager outreach and monitoring

Locations

Country	Name	City	State
United States	Harvard Medical School	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Harvard Medical School	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States,